AMG 162: Phase II ongoing

One-year data from an ongoing U.S. Phase II trial in 411 women showed that AMG 162 increased BMD at the lumbar

Read the full 211 word article

User Sign In

Article Purchase

This article may not be distributed to non-subscribers

PURCHASE THIS ARTICLE FOR LIMITED ONE-TIME DISTRIBUTION AND WEBSITE POSTING $995.00 USD

PURCHASE